Connect your AI

Biohaven BHVN Other Income (Expense)

Other Income (Expense) at other companies

Eli LillyLLY

-$65M+72.8%

Xenon PharmaceuticalsXENE

$7.46M-8.2%

Rapport Therapeutics, Inc.RAPP

$4.36M+43.1%

Vir Biotechnology, Inc.VIR

$6.77M-63.6%

uniQureQURE

$3.77M-54.6%

Roivant SciencesROIV

$12.57M+542%

Segments

By segment

Reportable Segment-$168K+65.9%

Other financials

Income statement

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

Market cap$2.25B-48.1%

Enterprise value$2.26B-46.3%

Returns & leverage

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Biohaven's other income (expense)?: Biohaven (BHVN) reported other income (expense) of $168K in Q1 2026.
How has Biohaven's other income (expense) changed year-over-year?: Biohaven's other income (expense) decreased by 65.9% year-over-year, from $493K to $168K.
What is the long-term trend for Biohaven's other income (expense)?: Over 2 years (2022 to 2024), Biohaven's other income (expense) has grown at a 354.4% compound annual growth rate (CAGR), from -$1.91M to $39.42M.
What does other income (expense) mean?: Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.